Clinical Trial Update: HerpeVac Trial for Young Women [Phase 3]

View source ↗

Summary

Phase 3 trial update for HerpeVac in young women completed; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Infection

Drugs mentioned

• Herpevac (HSV-2 glycoprotein B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Simplex Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-11-03